Major depressive disorder (MDD) has been associated with reduced leukocyte telomere length (LTL). It is not known, however, whether psychosocial and behavioral protective factors moderate this association. In the current study, we examine whether multisystem resiliency -defined by healthy emotion regulation, strong social connections, and health behaviors (sleep and exercise) -predicts LTL and mitigates previously demonstrated associations between depression diagnosis and LTL. LTL was measured, using a quantitative PCR assay, in 954 patients with stable cardiovascular disease in the Heart and Soul Study. In a fully adjusted model, high multisystem resiliency predicted longer LTL (b = 80.00, SE = 27.17, p = .003), whereas each individual factor did not. Multisystem resiliency significantly moderated the MDD-LTL association (p = .02). Specifically, MDD was significantly related to LTL at 1 SD below the mean of multisystem resiliency (b = À142.86, SE = 56.46, p = .01), but not at 1 SD above the mean (b = 49.07, SE = 74.51, p = .51). This study suggests that MDD associations with biological outcomes should be examined within a psychosocial-behavioral context, because this context shapes the nature of the direct relationship. Further research should explore the cognitive, neural, and other physiological pathways through which multisystem resiliency may confer biological benefit.
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Introduction
Major depressive disorder (MDD) plays a significant role in the development of aging related disorders (Evans et al., 2005; KiecoltGlaser and Glaser, 2002) , including cardiovascular disease (CVD) (Musselman et al., 1998) , immune disorders (Irwin and Miller, 2007) , and early mortality (Arfken et al., 1999; Schulz et al., 2000) . Key biological pathways in the pathogeneses of these diseases have also been linked to depression, including insulin resistance (Winokur et al., 1988) In recent years, increasing attention has been directed to the role of cellular aging in health, indexed in part by leukocyte telomere length (LTL) (Epel, 2009; Wolkowitz et al., 2010) . Telomeres are protective DNA-protein complex caps at the ends of chromosomes, and shortening of the telomeric DNA repeat tracts is associated with increased risk for aging-related diseases. The cellular enzyme telomerase adds the telomeric TTAGGG repeat sequences onto the ends of telomeres, counteracting or delaying shortening during cell division. If telomeres become critically short, normal cells commonly enter a senescent state, marked by overproduction and release of pro-inflammatory cytokines (Blackburn, 2010) . Telomeres are not solely biomarkers of disease, as experiments in rodents implicate telomere shortening and lower telomerase activity as causes of mitochondrial damage, increased oxidative stress, and damage to tissues (Jaskelioff et al., 2011; Perez-Rivero et al., 2006; Sahin et al., 2011) .
To date, several studies have associated either current MDD (Hartmann et al., 2010; Simon et al., 2006; Wikgren et al., 2012) or history of MDD (Wolkowitz et al., 2011) with shorter telomeres in healthy patients. Additionally, our recent work suggests that both diagnosed depression and depressive symptomatology are related to shorter telomeres in patients with coronary heart disease (Hoen et al., 2011) . Protective intrapersonal, interpersonal, and behavioral factors that mitigate the associations between MDD and LTL remain unexplored. A large literature highlights key psychological, social, and behavioral features that predict physical health. In the current study, we examine the independent and combined associations of such key features with telomere length
